AN2 Therapeutics, Inc. · NASDAQ:ANTX
Eizen Joshua M sold 2,826 AN2 Therapeutics, Inc. shares (Form 4)
Traded Nov 5, 2026 · Filed Nov 6, 2026
On Nov 5, 2026, Eizen Joshua M (See Remarks) sold 2,826 AN2 Therapeutics, Inc. shares at US$4.22 for US$11,926, leaving 207,546 shares. Filed Nov 6, 2026 (Form 4).
- Sold
- 2,826 shares
- Price
- US$4.22
- Value
- US$11,926
- Holding after
- 207,546 shares
- Trading plan
- No
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Common Stock | Sale | 2,826 | US$4.22 | 207,546 | Direct |
Source
Download original · View original at SEC
Related
- AN2 Therapeutics, Inc.
- Eizen Joshua M
- AN2 Therapeutics, Inc. shareholders
- Form 4 · Eizen Joshua M · Jul 10, 2026
- Schedule 13G/A · Commodore Capital LP · Nov 16, 2026
- Schedule 13G/A · Eric Easom · Nov 13, 2026
- Schedule 13G/A · Coastlands Capital LP · Nov 13, 2026
- Form 4 · Aziz Kabeer · Oct 13, 2026
- Form 4 · Martin Patricia A. · Oct 13, 2026